Canadian Centre for Vaccinology
The Canadian Center for Vaccinology (CCfV) is a collaborative research center involving Dalhousie University, IWK Health, and Nova Scotia Health. It focuses on developing, implementing, and evaluating vaccine technologies and vaccines for infectious diseases, aiming to improve global and Canadian health. The center trains experts in these fields and conducts multidisciplinary research to advance vaccine development, policy, and public health initiatives, with a mission to drive vaccine innovation and a vision of accessible, innovative vaccines to prevent infectious diseases worldwide.
Industries
Nr. of Employees
small (1-50)
Canadian Centre for Vaccinology
Goldbloom RCC Pavilion, 4th floor, 5850/5980 University Avenue, Halifax, Canada
Products
Vaccine Research and Development
Research and development of vaccines to prevent and treat diseases, including therapeutic vaccines for conditions like cancer.
Clinical Trials
Conducting clinical trials to test the safety and efficacy of vaccines and medicines for various diseases.
Vaccine Challenge Unit
A specialized unit designed for human challenge studies, featuring isolation rooms to control infectious agents.
Health Policy and Translation
Research on vaccine access, acceptability, ethics, and policy development to inform public health strategies.
Laboratory Services
Providing laboratory support for clinical trials, including specimen handling, storage, and various assays for infectious diseases.
Training and Education
Programs to develop and train experts in vaccine technologies and research, encompassing a range of scientific disciplines.
Vaccine Research and Development
Research and development of vaccines to prevent and treat diseases, including therapeutic vaccines for conditions like cancer.
Clinical Trials
Conducting clinical trials to test the safety and efficacy of vaccines and medicines for various diseases.
Vaccine Challenge Unit
A specialized unit designed for human challenge studies, featuring isolation rooms to control infectious agents.
Health Policy and Translation
Research on vaccine access, acceptability, ethics, and policy development to inform public health strategies.
Laboratory Services
Providing laboratory support for clinical trials, including specimen handling, storage, and various assays for infectious diseases.
Training and Education
Programs to develop and train experts in vaccine technologies and research, encompassing a range of scientific disciplines.
Services
Comprehensive clinical trial management covering recruitment, staffing, equipment and monitoring support across all trial phases.
CL2 laboratory support for clinical trials, referral testing for collaborators and industry, and independent infectious disease and immunology research.
Secure data systems, eCRF design, database development, quality control processes, and statistical analysis for clinical studies.
Specialized facility operations and clinical teams to conduct controlled human infection/challenge studies requiring a controlled inpatient environment and close clinical monitoring.
Operational support for study setup and execution, including protocol development, ethics submissions, staffing, administration, and close-out.
Comprehensive clinical trial management covering recruitment, staffing, equipment and monitoring support across all trial phases.
CL2 laboratory support for clinical trials, referral testing for collaborators and industry, and independent infectious disease and immunology research.
Secure data systems, eCRF design, database development, quality control processes, and statistical analysis for clinical studies.
Specialized facility operations and clinical teams to conduct controlled human infection/challenge studies requiring a controlled inpatient environment and close clinical monitoring.
Operational support for study setup and execution, including protocol development, ethics submissions, staffing, administration, and close-out.
Expertise Areas
- Clinical trial management
- Human challenge studies (controlled human infection models)
- Vaccine discovery and immunology research
- Vaccine evaluation and first-in-human studies
Key Technologies
- Controlled human infection model methodologies
- Containment level 2 laboratory operations
- Electronic case report form (eCRF) and clinical database systems
- mRNA vaccine clinical platforms
News & Updates
A public event exploring immune responses and diagnostics related to maternal vaccination, scheduled for June 9, 2025.
Event on July 2, 2025, focusing on adverse pregnancy outcomes, with additional talks on July 3rd.
Seminar on May 6, 2025, discussing the BCG vaccine's history and future.
A full-day event on February 6, 2025, showcasing research in infectious diseases by CCfV and partners.
Coverage of the symposium held on July 2, 2025, led by Dr. Tobias Kollmann, highlighting key insights.
Announcement of Dr. Moss receiving the award on June 18, 2025, for her work on health equity and vaccinology.
A public event exploring immune responses and diagnostics related to maternal vaccination, scheduled for June 9, 2025.
Event on July 2, 2025, focusing on adverse pregnancy outcomes, with additional talks on July 3rd.
Seminar on May 6, 2025, discussing the BCG vaccine's history and future.
A full-day event on February 6, 2025, showcasing research in infectious diseases by CCfV and partners.
Coverage of the symposium held on July 2, 2025, led by Dr. Tobias Kollmann, highlighting key insights.
Announcement of Dr. Moss receiving the award on June 18, 2025, for her work on health equity and vaccinology.